>20 years experience in drug discovery and development in the pharmaceutical industry, specialising in integrated preclinical; expertise and successful track record in Scientific Due Diligence (>50 global assessments in Europe, USA, Japan, Central/South America and Asia). Track record in incubating early drug discovery biology and platform technology (I.e. translating innovations into proof-of-mechanism).
Expertise in developing, negotiating and establishing scientific collaborations with world-leading academic experts. Expertise in CMC/chemical development (authored/co-authored CMC sections in >10 INDs/IMPDs, 1 NDA & MAA). Scientific publication track record with >50 scientific papers (incl. Nature, JACS, Anal. Chem., Anal Biochem.), co-authored 4 book chapters, book editor and co-inventor on 2 patents.